この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1999/2/161 分で読めます
Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics; Availability; Extension of Comment Period
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is extending until April 14, 1999, the comment period for the draft guidance for industry entitled ``Developing Medical Imaging Drugs and Biologics.'' FDA published a notice of availability of the draft guidance in the Federal Register of October 14, 1998 (63 FR 55067). FDA is taking this action in response to requests for an extension.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →